Life Science Tools Market - Top Companies and Manufacturers

  • Report ID: 6164
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Companies Dominating the Life Science Tools Landscape

    As life science tools are always developing and advancing technologically, there is intense competition in the global market for these tools. Furthermore, the industry participants employ cooperation, amalgamation, alliance, and additional inorganic expansion tactics to provide an extensive array of inventive and appealing resolutions to their clientele.

    • Agilent Technologies, Inc.
      •  Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche AG
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc. 
    • Merck KGaA
    • QIAGEN N.V. 
    • Oxford Instruments plc
    • GE HealthCare Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Hitachi Ltd. executed a stock purchase agreement with MAX Agilent Technologies, Inc. to improve customer access to genomic tools, teamed with Biosciences, Inc. to integrate the AVITI System with Sure Select target enrichment panels.
  • QIAGEN established an exclusive strategic agreement with California-based population genomics company Helix, to enhance companion diagnostics for genetic disorders.

Author Credits:  Radhika Pawar


  • Report ID: 6164
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of life science tools is evaluated at USD 194.77 billion.

The life science tools market size was valued at USD 178.49 billion in 2024 and is set to exceed USD 726.31 billion by 2037, registering over 11.4% CAGR during the forecast period i.e., between 2025-2037. Increased emphasis on companion diagnostics and precision medicine will fuel the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, influenced by adoption of proteomics, oncology, and genomics, oncology, and diagnostic screening in the region.

The major players in the market are F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Oxford Instruments plc, GE HealthCare Technologies, Inc., Becton, Dickinson and Company, Shimadzu Corporation and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample